Chapter/Section Purchase

1 Study Coverage
1.1 Devices for Inhaled Medications Product Introduction
1.2 Global Devices for Inhaled Medications Outlook 2017 VS 2022 VS 2028
1.2.1 Global Devices for Inhaled Medications Sales in US$ Million for the Year 2017-2028
1.2.2 Global Devices for Inhaled Medications Sales in Volume for the Year 2017-2028
1.3 United States Devices for Inhaled Medications Outlook 2017 VS 2022 VS 2028
1.3.1 United States Devices for Inhaled Medications Sales in US$ Million for the Year 2017-2028
1.3.2 United States Devices for Inhaled Medications Sales in Volume for the Year 2017-2028
1.4 Devices for Inhaled Medications Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Devices for Inhaled Medications in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Devices for Inhaled Medications Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Devices for Inhaled Medications Market Dynamics
1.5.1 Devices for Inhaled Medications Industry Trends
1.5.2 Devices for Inhaled Medications Market Drivers
1.5.3 Devices for Inhaled Medications Market Challenges
1.5.4 Devices for Inhaled Medications Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Devices for Inhaled Medications Market Segment by Type
2.1.1 Dry Powder Inhalers
2.1.2 Metered-Dose Inhalers
2.1.3 Nebulizers
2.1.4 Soft Mist Inhaler
2.2 Global Devices for Inhaled Medications Market Size by Type
2.2.1 Global Devices for Inhaled Medications Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Devices for Inhaled Medications Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Devices for Inhaled Medications Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Devices for Inhaled Medications Market Size by Type
2.3.1 United States Devices for Inhaled Medications Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Devices for Inhaled Medications Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Devices for Inhaled Medications Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Devices for Inhaled Medications Market Segment by Application
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Household
3.2 Global Devices for Inhaled Medications Market Size by Application
3.2.1 Global Devices for Inhaled Medications Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Devices for Inhaled Medications Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Devices for Inhaled Medications Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Devices for Inhaled Medications Market Size by Application
3.3.1 United States Devices for Inhaled Medications Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Devices for Inhaled Medications Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Devices for Inhaled Medications Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Devices for Inhaled Medications Competitor Landscape by Company
4.1 Global Devices for Inhaled Medications Market Size by Company
4.1.1 Top Global Devices for Inhaled Medications Manufacturers Ranked by Revenue (2021)
4.1.2 Global Devices for Inhaled Medications Revenue by Manufacturer (2017-2022)
4.1.3 Global Devices for Inhaled Medications Sales by Manufacturer (2017-2022)
4.1.4 Global Devices for Inhaled Medications Price by Manufacturer (2017-2022)
4.2 Global Devices for Inhaled Medications Concentration Ratio (CR)
4.2.1 Devices for Inhaled Medications Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Devices for Inhaled Medications in 2021
4.2.3 Global Devices for Inhaled Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Devices for Inhaled Medications Manufacturing Base Distribution, Product Type
4.3.1 Global Devices for Inhaled Medications Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Devices for Inhaled Medications Product Type
4.3.3 Date of International Manufacturers Enter into Devices for Inhaled Medications Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Devices for Inhaled Medications Market Size by Company
4.5.1 Top Devices for Inhaled Medications Players in United States, Ranked by Revenue (2021)
4.5.2 United States Devices for Inhaled Medications Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Devices for Inhaled Medications Sales by Players (2020, 2021 & 2022)
5 Global Devices for Inhaled Medications Market Size by Region
5.1 Global Devices for Inhaled Medications Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Devices for Inhaled Medications Market Size in Volume by Region (2017-2028)
5.2.1 Global Devices for Inhaled Medications Sales in Volume by Region: 2017-2022
5.2.2 Global Devices for Inhaled Medications Sales in Volume Forecast by Region (2023-2028)
5.3 Global Devices for Inhaled Medications Market Size in Value by Region (2017-2028)
5.3.1 Global Devices for Inhaled Medications Sales in Value by Region: 2017-2022
5.3.2 Global Devices for Inhaled Medications Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Devices for Inhaled Medications Market Size YoY Growth 2017-2028
6.1.2 North America Devices for Inhaled Medications Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Devices for Inhaled Medications Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Devices for Inhaled Medications Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Devices for Inhaled Medications Market Size YoY Growth 2017-2028
6.3.2 Europe Devices for Inhaled Medications Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Devices for Inhaled Medications Market Size YoY Growth 2017-2028
6.4.2 Latin America Devices for Inhaled Medications Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Devices for Inhaled Medications Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Devices for Inhaled Medications Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Consort Medical
7.1.1 Consort Medical Corporation Information
7.1.2 Consort Medical Description and Business Overview
7.1.3 Consort Medical Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Consort Medical Devices for Inhaled Medications Products Offered
7.1.5 Consort Medical Recent Development
7.2 Inhalexper
7.2.1 Inhalexper Corporation Information
7.2.2 Inhalexper Description and Business Overview
7.2.3 Inhalexper Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Inhalexper Devices for Inhaled Medications Products Offered
7.2.5 Inhalexper Recent Development
7.3 Cambridge Consultants
7.3.1 Cambridge Consultants Corporation Information
7.3.2 Cambridge Consultants Description and Business Overview
7.3.3 Cambridge Consultants Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Cambridge Consultants Devices for Inhaled Medications Products Offered
7.3.5 Cambridge Consultants Recent Development
7.4 Hovione
7.4.1 Hovione Corporation Information
7.4.2 Hovione Description and Business Overview
7.4.3 Hovione Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Hovione Devices for Inhaled Medications Products Offered
7.4.5 Hovione Recent Development
7.5 Catalent, Inc
7.5.1 Catalent, Inc Corporation Information
7.5.2 Catalent, Inc Description and Business Overview
7.5.3 Catalent, Inc Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Catalent, Inc Devices for Inhaled Medications Products Offered
7.5.5 Catalent, Inc Recent Development
7.6 VertMarkets, Inc
7.6.1 VertMarkets, Inc Corporation Information
7.6.2 VertMarkets, Inc Description and Business Overview
7.6.3 VertMarkets, Inc Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.6.4 VertMarkets, Inc Devices for Inhaled Medications Products Offered
7.6.5 VertMarkets, Inc Recent Development
7.7 Qualicaps
7.7.1 Qualicaps Corporation Information
7.7.2 Qualicaps Description and Business Overview
7.7.3 Qualicaps Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Qualicaps Devices for Inhaled Medications Products Offered
7.7.5 Qualicaps Recent Development
7.8 3M
7.8.1 3M Corporation Information
7.8.2 3M Description and Business Overview
7.8.3 3M Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.8.4 3M Devices for Inhaled Medications Products Offered
7.8.5 3M Recent Development
7.9 Aerovance
7.9.1 Aerovance Corporation Information
7.9.2 Aerovance Description and Business Overview
7.9.3 Aerovance Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Aerovance Devices for Inhaled Medications Products Offered
7.9.5 Aerovance Recent Development
7.10 AstraZeneca
7.10.1 AstraZeneca Corporation Information
7.10.2 AstraZeneca Description and Business Overview
7.10.3 AstraZeneca Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.10.4 AstraZeneca Devices for Inhaled Medications Products Offered
7.10.5 AstraZeneca Recent Development
7.11 Boehringer Ingelheim
7.11.1 Boehringer Ingelheim Corporation Information
7.11.2 Boehringer Ingelheim Description and Business Overview
7.11.3 Boehringer Ingelheim Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Boehringer Ingelheim Devices for Inhaled Medications Products Offered
7.11.5 Boehringer Ingelheim Recent Development
7.12 Chiesi
7.12.1 Chiesi Corporation Information
7.12.2 Chiesi Description and Business Overview
7.12.3 Chiesi Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Chiesi Products Offered
7.12.5 Chiesi Recent Development
7.13 Cipla
7.13.1 Cipla Corporation Information
7.13.2 Cipla Description and Business Overview
7.13.3 Cipla Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Cipla Products Offered
7.13.5 Cipla Recent Development
7.14 Civitas/Alkermes
7.14.1 Civitas/Alkermes Corporation Information
7.14.2 Civitas/Alkermes Description and Business Overview
7.14.3 Civitas/Alkermes Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Civitas/Alkermes Products Offered
7.14.5 Civitas/Alkermes Recent Development
7.15 GlaxoSmithKline
7.15.1 GlaxoSmithKline Corporation Information
7.15.2 GlaxoSmithKline Description and Business Overview
7.15.3 GlaxoSmithKline Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.15.4 GlaxoSmithKline Products Offered
7.15.5 GlaxoSmithKline Recent Development
7.16 Hovione
7.16.1 Hovione Corporation Information
7.16.2 Hovione Description and Business Overview
7.16.3 Hovione Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Hovione Products Offered
7.16.5 Hovione Recent Development
7.17 Mannkind
7.17.1 Mannkind Corporation Information
7.17.2 Mannkind Description and Business Overview
7.17.3 Mannkind Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Mannkind Products Offered
7.17.5 Mannkind Recent Development
7.18 Mantecorp
7.18.1 Mantecorp Corporation Information
7.18.2 Mantecorp Description and Business Overview
7.18.3 Mantecorp Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Mantecorp Products Offered
7.18.5 Mantecorp Recent Development
7.19 Meda
7.19.1 Meda Corporation Information
7.19.2 Meda Description and Business Overview
7.19.3 Meda Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Meda Products Offered
7.19.5 Meda Recent Development
7.20 MicroDose Therapeutx
7.20.1 MicroDose Therapeutx Corporation Information
7.20.2 MicroDose Therapeutx Description and Business Overview
7.20.3 MicroDose Therapeutx Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.20.4 MicroDose Therapeutx Products Offered
7.20.5 MicroDose Therapeutx Recent Development
7.21 Novartis
7.21.1 Novartis Corporation Information
7.21.2 Novartis Description and Business Overview
7.21.3 Novartis Devices for Inhaled Medications Sales, Revenue and Gross Margin (2017-2022)
7.21.4 Novartis Products Offered
7.21.5 Novartis Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Devices for Inhaled Medications Industry Chain Analysis
8.2 Devices for Inhaled Medications Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Devices for Inhaled Medications Distributors
8.3 Devices for Inhaled Medications Production Mode & Process
8.4 Devices for Inhaled Medications Sales and Marketing
8.4.1 Devices for Inhaled Medications Sales Channels
8.4.2 Devices for Inhaled Medications Distributors
8.5 Devices for Inhaled Medications Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer